Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
All-trans-retinoic acid (at-RA) induces cell differentiation in a wide variety of cell types, including F9 embryonic teratocarcinoma cells, and can influence axial pattern formation during embryonic development. We now identify a novel retinoid synthetic pathway in differentiating F9 cells that results in the intracellular production of 4-oxoretinol (4-oxo-ROL) from retinol (vitamin A). Approximately 10-15% of the total retinol in the culture is metabolized to 4-hydroxyretinol and 4-oxo-ROL by the at-RA-treated, differentiating F9 cells over an 18-hr period, but no detectable metabolism of all-trans-retinol to at-RA or 9-cis-retinoic acid is observed in these cells. Remarkably, we show that 4-oxo-ROL can bind and activate transcription of the retinoic acid receptors whereas all-trans-retinol shows neither activity. Low doses of 4-oxo-ROL (e.g., 10(-9) or 10(-10 M) can activate the retinoic acid receptors even though, unlike at-RA, 4-oxo-ROL does not contain an acid moiety at the carbon 15 position. 4-oxo-ROL does not bind or transcriptionally activate the retinoid X receptors. Treatment of F9 cells with 4-oxo-ROL induces differentiation without conversion to the acid and 4-oxo-ROL is active in causing axial truncation when administered to Xenopus embryos at the blastula stage. Thus, 4-oxo-ROL is a natural, biologically active retinoid that is present in differentiated F9 cells. Our data suggest that 4-oxo-ROL may be a novel signaling molecule and regulator of cell differentiation.
Allenby,
Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids.
1993, Pubmed
Allenby,
Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids.
1993,
Pubmed Allenby,
Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid.
1994,
Pubmed Boylan,
Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells.
1991,
Pubmed Boylan,
The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells.
1992,
Pubmed Buck,
Intracellular signaling by 14-hydroxy-4,14-retro-retinol.
1991,
Pubmed Buck,
Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology.
1993,
Pubmed Chen,
Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases.
1994,
Pubmed DeLean,
Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.
1978,
Pubmed Gubler,
Metabolism of retinoids by embryonal carcinoma cells.
1985,
Pubmed Heyman,
9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.
1992,
Pubmed LaRosa,
An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem cell differentiation.
1988,
Pubmed LaRosa,
Early retinoic acid-induced F9 teratocarcinoma stem cell gene ERA-1: alternate splicing creates transcripts for a homeobox-containing protein and one lacking the homeobox.
1988,
Pubmed Leo,
New pathway for retinol metabolism in liver microsomes.
1985,
Pubmed Leo,
Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8.
1989,
Pubmed Levin,
9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.
1992,
Pubmed McClean,
Liquid-chromatographic assay for retinol (vitamin A) and retinol analogs in therapeutic trials.
1982,
Pubmed Nervi,
Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.
1992,
Pubmed Nervi,
Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells.
1989,
Pubmed Ostrowski,
The N-terminal portion of domain E of retinoic acid receptors alpha and beta is essential for the recognition of retinoic acid and various analogs.
1995,
Pubmed Perlmann,
Determinants for selective RAR and TR recognition of direct repeat HREs.
1993,
Pubmed Pijnappel,
The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification.
1993,
Pubmed
,
Xenbase Repa,
All-trans-retinol is a ligand for the retinoic acid receptors.
1993,
Pubmed Roberts,
Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal.
1992,
Pubmed Scharf,
Axis determination in eggs of Xenopus laevis: a critical period before first cleavage, identified by the common effects of cold, pressure and ultraviolet irradiation.
1983,
Pubmed
,
Xenbase Tate,
Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha.
1994,
Pubmed Umesono,
Retinoic acid and thyroid hormone induce gene expression through a common responsive element.
1988,
Pubmed Vasios,
A retinoic acid-responsive element is present in the 5' flanking region of the laminin B1 gene.
1989,
Pubmed Williams,
Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells.
1985,
Pubmed
